Aegerion amends IPO

Aegerion Pharmaceuticals Inc. (Bridgewater, N.J.) amended its IPO and hopes to sell 4.7 million shares at $14-$16. A $15 price would raise $70 million and value the company at $230.8 million. In August, the company filed for an IPO for the third time to raise up to $86.3 million. Leerink; Lazard; Needham; Canaccord; and Collins Stewart are underwriters for the offering. Aegerion filed for an IPO in March 2007 and November 2007, but withdrew the proposals in June 2007 and December 2008, respectively, citing market conditions. ...